China · Delayed Price · Currency is CNY Cisen Pharmaceutical Statistics
Total Valuation
SHA:603367 has a market cap or net worth of CNY 7.81 billion. The enterprise value is 4.54 billion.
| Market Cap | 7.81B |
| Enterprise Value | 4.54B |
Important Dates
The next estimated earnings date is Friday, April 3, 2026.
| Earnings Date | Apr 3, 2026 |
| Ex-Dividend Date | Oct 13, 2025 |
Share Statistics
SHA:603367 has 452.75 million shares outstanding. The number of shares has increased by 0.89% in one year.
| Current Share Class | 452.75M |
| Shares Outstanding | 452.75M |
| Shares Change (YoY) | +0.89% |
| Shares Change (QoQ) | +3.48% |
| Owned by Insiders (%) | 6.50% |
| Owned by Institutions (%) | 2.08% |
| Float | 204.29M |
Valuation Ratios
The trailing PE ratio is 15.96.
| PE Ratio | 15.96 |
| Forward PE | n/a |
| PS Ratio | 2.19 |
| PB Ratio | 1.26 |
| P/TBV Ratio | 1.31 |
| P/FCF Ratio | 11.13 |
| P/OCF Ratio | 9.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.51, with an EV/FCF ratio of 6.48.
| EV / Earnings | 9.22 |
| EV / Sales | 1.28 |
| EV / EBITDA | 7.51 |
| EV / EBIT | 11.43 |
| EV / FCF | 6.48 |
Financial Position
The company has a current ratio of 4.05, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.05 |
| Quick Ratio | 3.32 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 0.06 |
| Interest Coverage | 227.26 |
Financial Efficiency
Return on equity (ROE) is 8.24% and return on invested capital (ROIC) is 11.91%.
| Return on Equity (ROE) | 8.24% |
| Return on Assets (ROA) | 3.29% |
| Return on Invested Capital (ROIC) | 11.91% |
| Return on Capital Employed (ROCE) | 6.27% |
| Weighted Average Cost of Capital (WACC) | 6.03% |
| Revenue Per Employee | 1.08M |
| Profits Per Employee | 149,243 |
| Employee Count | 3,302 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.15 |
Taxes
In the past 12 months, SHA:603367 has paid 63.31 million in taxes.
| Income Tax | 63.31M |
| Effective Tax Rate | 11.30% |
Stock Price Statistics
The stock price has increased by +26.20% in the last 52 weeks. The beta is 0.33, so SHA:603367's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +26.20% |
| 50-Day Moving Average | 18.19 |
| 200-Day Moving Average | 19.34 |
| Relative Strength Index (RSI) | 33.42 |
| Average Volume (20 Days) | 14,092,247 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603367 had revenue of CNY 3.56 billion and earned 492.80 million in profits. Earnings per share was 1.08.
| Revenue | 3.56B |
| Gross Profit | 1.87B |
| Operating Income | 397.49M |
| Pretax Income | 560.14M |
| Net Income | 492.80M |
| EBITDA | 603.19M |
| EBIT | 397.49M |
| Earnings Per Share (EPS) | 1.08 |
Balance Sheet
The company has 3.34 billion in cash and 43.06 million in debt, with a net cash position of 3.30 billion or 7.29 per share.
| Cash & Cash Equivalents | 3.34B |
| Total Debt | 43.06M |
| Net Cash | 3.30B |
| Net Cash Per Share | 7.29 |
| Equity (Book Value) | 6.19B |
| Book Value Per Share | 13.59 |
| Working Capital | 3.91B |
Cash Flow
In the last 12 months, operating cash flow was 813.48 million and capital expenditures -112.28 million, giving a free cash flow of 701.19 million.
| Operating Cash Flow | 813.48M |
| Capital Expenditures | -112.28M |
| Free Cash Flow | 701.19M |
| FCF Per Share | 1.55 |
Margins
Gross margin is 52.61%, with operating and profit margins of 11.16% and 13.83%.
| Gross Margin | 52.61% |
| Operating Margin | 11.16% |
| Pretax Margin | 15.72% |
| Profit Margin | 13.83% |
| EBITDA Margin | 16.93% |
| EBIT Margin | 11.16% |
| FCF Margin | 19.68% |
Dividends & Yields
This stock pays an annual dividend of 0.38, which amounts to a dividend yield of 2.20%.
| Dividend Per Share | 0.38 |
| Dividend Yield | 2.20% |
| Dividend Growth (YoY) | -37.80% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 41.27% |
| Buyback Yield | -0.89% |
| Shareholder Yield | 1.26% |
| Earnings Yield | 6.31% |
| FCF Yield | 8.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603367 has an Altman Z-Score of 5.09 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.09 |
| Piotroski F-Score | 6 |